News
Remiges selected as Certified VC by the AEMD Strengthening Program for Pharmaceutical Venture Ecosystem
06/30/2022
The Japan Agency for Medical Research and Development (AMED) in Japan announced today that Remiges was selected as one of the Certified VCs in Strengthening Program for Pharmaceutical Venture Ecosystem.
The program provides certain services including financial supports for drug discovery startup companies in which Certified VCs invest.
For more detailed information please visit the above AMED web pages.